Published in J Pain on April 01, 2004
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ (2010) 3.46
The need for knowledge translation in chronic pain. Pain Res Manag (2009) 2.56
Neuropathic pain: a practical guide for the clinician. CMAJ (2006) 1.79
Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract (2007) 1.67
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol (2011) 1.21
Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line. J Peripher Nerv Syst (2007) 1.16
Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database. Pain Res Manag (2007) 1.07
Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther (2009) 1.05
The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population. Pain Med (2009) 1.01
Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain. J Pain (2012) 1.00
Using electronic health records data to identify patients with chronic pain in a primary care setting. J Am Med Inform Assoc (2013) 0.97
Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc (2006) 0.97
Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int (2009) 0.92
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Clinicoecon Outcomes Res (2014) 0.92
Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc (2010) 0.90
Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol (2013) 0.88
L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies. Curr Neuropharmacol (2006) 0.87
Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence (2011) 0.87
Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Cancer Nurs (2013) 0.85
Neuropathic low back pain in clinical practice. Eur J Pain (2016) 0.84
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
A meta-analytic approach to estimating nocebo effects in neuropathic pain trials. J Neurol (2011) 0.83
Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Transl Med (2012) 0.82
A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients. BMC Health Serv Res (2009) 0.82
Multivariate analysis of chronic pain patients undergoing lidocaine infusions: increasing pain severity and advancing age predict likelihood of clinically meaningful analgesia. Clin J Pain (2007) 0.82
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract (2012) 0.81
Electroacupuncture to treat painful diabetic neuropathy: study protocol for a three-armed, randomized, controlled pilot trial. Trials (2013) 0.81
Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical. J Pain Res (2011) 0.80
The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Public Health (2007) 0.80
Chronic pain and health care spending: an analysis of longitudinal data from the Medical Expenditure Panel Survey. Health Serv Res (2014) 0.79
Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials. BMJ Open (2014) 0.79
Out-of-pocket prices of opioid analgesics in the United States, 1999-2004. Pain Med (2009) 0.78
Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics. Pain Res Treat (2014) 0.78
Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems. Pharmacol Res (2016) 0.77
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. BMC Neurol (2013) 0.77
Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy. PLoS One (2016) 0.77
A burden of illness study for neuropathic pain in Europe. Clinicoecon Outcomes Res (2016) 0.76
Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia. Ann Dermatol (2011) 0.76
Health care utilization and expenditures among Medicaid beneficiaries with neuropathic pain following spinal cord injury. J Pain Res (2014) 0.75
An Algorithm for Neuropathic Pain Management in Older People. Drugs Aging (2016) 0.75
Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain. Neuropsychiatr Dis Treat (2015) 0.75
Neuropathic pain referrals to a multidisciplinary pediatric cancer pain service. Pain Manag Nurs (2012) 0.75
Modulation of Spinal GABAergic Inhibition and Mechanical Hypersensitivity following Chronic Compression of Dorsal Root Ganglion in the Rat. Neural Plast (2015) 0.75
Gabapentinoids for chronic low back pain: a protocol for systematic review and meta-analysis of randomised controlled trials. BMJ Open (2016) 0.75
Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents. J Pain (2015) 0.75
Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndrome. Pain Ther (2013) 0.75
Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials. J Pain Res (2017) 0.75
Anatomical study of middle cluneal nerve entrapment. J Pain Res (2017) 0.75
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05
Human and economic burden of generalized anxiety disorder. Depress Anxiety (2008) 1.92
The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain (2006) 1.82
How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain (2010) 1.80
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Is sepsis accurately coded on hospital bills? Value Health (2002) 1.60
Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care (2009) 1.52
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40
Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain (2003) 1.39
Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface (2004) 1.38
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15
Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin (2009) 1.06
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01
Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01
Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00
Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96
Adherence with migraine prophylaxis in clinical practice. Pain Pract (2012) 0.95
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. J Rheumatol (2008) 0.90
Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother (2008) 0.89
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol (2006) 0.88
Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care. Clin Drug Investig (2004) 0.87
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med (2010) 0.87
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis. J Drugs Dermatol (2010) 0.86
Initial treatment failure in patients with complicated skin and skin structure infections. Surg Infect (Larchmt) (2013) 0.86
Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin (2007) 0.85
Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009. Am J Med Sci (2014) 0.85
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. BMC Geriatr (2009) 0.84
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Ann Pharmacother (2012) 0.84
The impact of seizures and adverse effects on global health ratings. Epilepsy Behav (2007) 0.84
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
Identification of patients receiving peritoneal dialysis using health insurance claims data. Clin Ther (2009) 0.83
Treatment of peripheral neuropathic pain: a simulation model. Eur J Pain (2005) 0.83
Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study. BMC Pulm Med (2012) 0.83
Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm (2002) 0.83
Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Pract (2008) 0.82
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain (2007) 0.82
7-Valent pneumococcal conjugate vaccine and lower respiratory tract infections: effectiveness of a 2-dose versus 3-dose primary series. Vaccine (2009) 0.82
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study. BMC Psychiatry (2012) 0.82
Excess risk of diabetes in persons with hypertension. J Diabetes Complications (2008) 0.82
Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med (2011) 0.82
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective. Eur J Health Econ (2009) 0.81
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis. Clin Ther (2005) 0.81
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Pharmacoeconomics (2004) 0.80
Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy. Epilepsia (2007) 0.80
Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia. Clin Ther (2008) 0.80
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapy. Clin Ther (2012) 0.80
Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry (2011) 0.78
Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? Eur J Pain (2008) 0.78
Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract (2008) 0.77
Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study. BMC Psychiatry (2012) 0.77
Prophylaxis against venous thromboembolism in hospitalized medically ill patients. Circ Cardiovasc Qual Outcomes (2013) 0.77
Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia. Clin Ther (2003) 0.77
Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma. J Med Econ (2013) 0.76
Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens. Expert Opin Pharmacother (2012) 0.76
Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan. Blood Press Suppl (2008) 0.76
Clinical and economic consequences of post-operative infections following major elective surgery in U.S. hospitals. Surg Infect (Larchmt) (2014) 0.76
Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life. J Pain Symptom Manage (2003) 0.76
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension. Am J Health Syst Pharm (2007) 0.76
Response to Lamotte et Al. "A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.". Diabetes Care (2002) 0.75
Clinical relevance of bleeding index. Arch Intern Med (2003) 0.75
Clinical and Economic Burden of Peristomal Skin Complications in Patients With Recent Ostomies. J Wound Ostomy Continence Nurs (2017) 0.75
Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention. Ann Pharmacother (2005) 0.75
Use of tricyclic antidepressants in older patients with painful neuropathies. Eur J Clin Pharmacol (2006) 0.75
Cost of venous thromboembolism in hospitalized medically ill patients. Am J Health Syst Pharm (2013) 0.75